+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

From
Lifestyle Drugs - Global Strategic Business Report - Product Thumbnail Image

Lifestyle Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 184 Pages
  • Global
From
Liraglutide Market Report 2024 - Product Thumbnail Image

Liraglutide Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Orlistat Market Report 2024 - Product Thumbnail Image

Orlistat Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Liraglutide and Semaglutide Market Report 2024 - Product Thumbnail Image

Liraglutide and Semaglutide Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Body Fat Reduction Market Report 2025 - Product Thumbnail Image

Body Fat Reduction Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Hypothalamic Obesity (HO) - Pipeline Insight, 2024 - Product Thumbnail Image

Hypothalamic Obesity (HO) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
HET Obesity/POMC Deficiency Obesity - Pipeline Insight, 2024 - Product Thumbnail Image

HET Obesity/POMC Deficiency Obesity - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
Anti-obesity Medication Market - Product Thumbnail Image

Anti-obesity Medication Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
Weight Loss/Weight Management (Obesity) - Pipeline Insight, 2024 - Product Thumbnail Image

Weight Loss/Weight Management (Obesity) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more